Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) has received an average rating of “Moderate Buy” from the seven research firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a strong buy rating to the company.
Several equities research analysts have issued reports on the stock. Barclays upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. JPMorgan Chase & Co. downgraded shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research report on Thursday, August 29th. Sanford C. Bernstein lowered Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 4th. Citigroup upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. Finally, UBS Group raised Reckitt Benckiser Group to a “strong-buy” rating in a report on Wednesday, September 18th.
Check Out Our Latest Stock Report on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Performance
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- How to Use Stock Screeners to Find Stocks
- How to Master Trading Discipline: Overcome Emotional Challenges
- How to Invest in the FAANG Stocks
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- How to Invest in Small Cap Stocks
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.